Loading interface...

Stalia A (40/10 mg) Tablet

Manufactured byWanbury Ltd.
ContainsTelmisartan (40 mg) + Atorvastatin (10 mg)
Description

Stalia A (40/10 mg) Tablet is a combination medicine used for the treatment of patients with both high blood pressure and hyperlipidemia. Patients are advised to follow a strict exercise and diet regimen along with this medicine to get the best possible effect. This medicine is not recommended for use in patients below 18 years of age.

Side effects

Major & minor side effects for Stalia A (40/10 mg) Tablet

  • Cough
  • Difficulty in swallowing
  • Impaired liver function
  • Joint pain
  • Muscle pain
  • Runny Nose
  • Difficulty in breathing
  • Insomnia
  • Changes in vision
  • Dizziness
  • Increased heartbeat
  • Difficulty or painful urination
  • Abdominal pain
  • Diarrhea
  • Weakness
  • Fever

Uses of Stalia A (40/10 mg) Tablet

What is it prescribed for?

  • Coexisting essential hypertension and hyperlipidemia
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The antihypertensive effect of this medicine can be observed within 1 to 2 hours. The anti-hyperlipidemic effect of this medicine is cumulative and may take up to 3 to 5 days to show its results.
  • How long do the effects of this medicine last?
    The antihypertensive effect of this medicine lasts for an average duration of 24 hours. The anti-hyperlipidemic effect of this medicine may last for an average duration of 3 to 4 days after the onset of action.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, lightheadedness, and fainting. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women due to the increased risk of fetal harm. Your doctor may prescribe a safer alternative based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Liver disease

This medicine is not recommended for use in patients with active liver diseases since it may worsen the patient's condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to atorvastatin, telmisartan, or any other angiotensin receptor blockers.

Aliskiren

Coadministration of aliskiren and this combination medicine is not recommended due to the increased risk of serious adverse effects. This risk is especially higher in the elderly population and in patients with diabetes and kidney diseases.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women due to the increased risk of fetal harm. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Cognitive impairment

This medicine may cause forgetfulness, memory loss, confusion, etc. in some patients. These side effects are reversible and usually disappear once the medicine is discontinued.

Altered blood sugar levels

This medicine may cause an alteration in the blood sugar levels. This risk is especially higher in patients with diabetes mellitus. Close monitoring of blood sugar levels may be necessary based on the clinical condition. Appropriate dose adjustments or replacement with a suitable alternative should be done under your doctor's supervision.

Muscle degradation and Rhabdomyolysis

This medicine may cause muscle breakdown and rhabdomyolysis in some patients, a condition which can be fatal. This may cause symptoms such as severe tiredness and weakness. This risk is especially higher in the elderly population and in patients with kidney diseases, hypothyroidism, and active muscle disorders. Report any unusual symptoms to the doctor immediately. Replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Heavy alcohol consumption

This medicine may cause liver and kidney injuries in patients consuming alcohol very frequently and in large quantities. Hence, consumption of alcohol should be avoided during treatment with this medicine.

Liver impairment

This medicine may cause moderate to severe liver impairment in some patients. Close monitoring of liver function is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Stroke

This medicine is not recommended for use in patients recovering from a stroke since it may worsen the patient's condition.

Hypotension

Symptomatic hypotension may occur in patients with volume depletion or patients who are treated with high doses of diuretics. It is advised to correct the condition before beginning treatment with this medicine.

Hyperkalemia

This medicine may increase the potassium levels in the blood (hyperkalemia). This may cause serious side effects such as fatal cardiac rhythm irregularities. It is advised to avoid potassium-rich foods (potatoes, bananas) and other medicines that may increase potassium levels (potassium-sparing diuretics and potassium supplements) during treatment with this medicine.

Pediatric population

This medicine is not recommended for use in children since the safety and efficacy of use are not clinically established.

Driving and operating machines

This medicine may cause dizziness or drowsiness in some patients. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, lightheadedness, and fainting. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Clarithromycin

Erythromycin

Azithromycin

Corticosteroids

Atazanavir

Cyclosporine

Aliskiren

Captopril

Insulin

Nonsteroidal anti-inflammatory medicines

Disease interactions

Liver Disease

This medicine is not recommended for use in patients with active liver diseases. In patients with liver impairment, this medicine should be used with extreme caution due to the increased risk of worsening of the patient's condition. Close monitoring of liver function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Diabetes

This medicine should be used with caution in patients with diabetes due to the increased risk of altered glucose levels. Close monitoring of blood glucose levels is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Congestive heart failure

This medicine should be used with caution in patients with congestive heart failure since it may worsen the patient's condition. Close monitoring of blood pressure, electrolytes level, and heart function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of adverse effects such as dizziness, muscle pain, fever and chills, headache, swelling of hands and feet, vomiting, skin rash, etc.
Lab interactions
Information not available.
Take this medicine as advised by your doctor. It can be taken with or without food. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Telmisartan relaxes the blood vessels and promotes the smooth flow of blood. Atorvastatin reduces the level of cholesterol in the blood. Their combination is thus helpful in treating both hyperlipidemia and high blood pressure.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Angiotensin receptor blockers, Statins, Antihyperlipidemic combinations, Miscellaneous antihypertensive combinations

Schedule

Schedule H

DailyMed - Telmisartan tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 1 March 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a907a7-fad9-a860-8639-4c6136c85734

Telmisartan: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 1 March 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a601249.html

[Internet]. 2017 [cited 1 March 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/27835

[Internet]. 2017 [cited 23 February 2017]. Available from:

https://www.medicines.org.uk/emc/PIL.2498.latest.pdf

Atorvastatin: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 6 October 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a600045.html

DailyMed - Atorvastatin calcium tablet, film coated [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 6 October 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9adb9e4-c495-9530-e5e3-7e3b01d53e4c
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 13 Nov 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.